In terms of market performance, Viking Therapeutics Inc had a somewhat regular. The highest value for the stock in the past year was $99.41 on 02/28/24, while the lowest value was $8.28 on 10/26/23.
52-week price history of VKTX Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Viking Therapeutics Inc’s current trading price is -45.53% away from its 52-week high, while its distance from the 52-week low is 553.99%. The stock’s price range for this period has remained between $8.28 and $99.41. The Healthcare sector company’s shares managed to surpass a trading volume of around 2.38 million for the day, which was noticeably lower compared to the shares’ average daily volume of 3.38 million over the last three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Financial Performance and Market Capitalization
Viking Therapeutics Inc (VKTX) has experienced a quarterly decline of -28.64% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 5.97B and boasts a workforce of 27 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 64.69, with a change in price of +23.55. Similarly, Viking Therapeutics Inc recorded 5,389,938 in trading volume during the last 100 days, posting a change of +76.96%.
VKTX Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for VKTX stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
VKTX Stock Stochastic Average
As of today, the raw stochastic average of Viking Therapeutics Inc over the past 50 days is 22.49%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 66.17%. Additionally, the Stochastic %K and %D values for the company were 49.47% and 40.63%, respectively, over the past 20 days.
VKTX Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The index has shown a price gain of 190.97% this year. Over the last six months, there has been a weaker performance of 197.69%. The price of VKTX leaped by -1.56% during the last 30 days period. For the last 5-days stocks have slided -2.11%.
